{
  "docId": "019de075-b7fd-707e-9848-cbfca2408f7c",
  "docSlug": "18b92232553b1610a38c1cd353f6efa7",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 28 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 28,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "context",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "QIDP stands for Qualified Infectious Disease Product.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-b7fd-707e-9848-cbfca2408f7c/5",
  "deckHref": "/decks/019de075-b7fd-707e-9848-cbfca2408f7c",
  "deckJsonHref": "/decks/019de075-b7fd-707e-9848-cbfca2408f7c.json",
  "deckAnchorHref": "/decks/019de075-b7fd-707e-9848-cbfca2408f7c#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.18,
        "x": 0.25,
        "y": 0.39
      },
      "kind": "image",
      "text": "WHO report cover",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "40ec6e3d-1966-4a1b-b662-2f03629d5e91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.14,
        "x": 0.06,
        "y": 0.49
      },
      "kind": "image",
      "text": "World Health Organization",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33657ea0-fc1f-4fa8-9120-7079699c2b49",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.45,
        "x": 0.43,
        "y": 0.34
      },
      "kind": "list",
      "text": "CRITICAL PRIORITY: Cryptococcal meningitis: Phase 2 success and QIDP; Aspergillosis: Preclinical data and QIDP. HIGH PRIORITY: Mucormycosis: Preclinical data",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c79c0bc-4208-403b-8911-6346adb830f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.52,
        "x": 0.43,
        "y": 0.19
      },
      "kind": "paragraph",
      "text": "Matinas is leveraging the safety and efficacy of MAT2203 to meet the needs of both critical and high priority groups identified by WHO",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78c13676-0b49-4ca2-843c-9cd00902573b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.33,
        "x": 0.05,
        "y": 0.19
      },
      "kind": "paragraph",
      "text": "The World Health Organization (WHO) released its first fungal priority pathogens list to guide research and development",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c50617e6-b7fb-431d-91eb-425c6305306f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.05,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "1:https://www.who.int/publications/i/item/9789240060241",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7db5a37-276d-4366-89e8-f904c16ae543",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.02,
        "y": 0.06
      },
      "kind": "title",
      "text": "Addressing Emerging Threats From Fungal Infections",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ddc7c18f-9826-4c4e-a7e0-128482e2f6b4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "ea351a51-d9c6-457e-96ce-d9c084d40241",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The deck presents the problem of emerging threats from fungal infections",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5ea2f8a3-5d0e-48dd-a24c-65a56e44ddce",
      "evidence": "The deck presents the limitations of current antifungal treatments and the potential of MAT2203",
      "position": 0,
      "objective": "Highlight the need for new antifungal treatments",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}